Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Giusti

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Biomedicines|August 28, 2025
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target TherapyDaria Maria Filippini, Donatella Romaniello, Francesca Carosi, et al.
Heliyon|December 17, 2024
Simultaneous care provision to patients with small cell lung cancer in Lazio region: Practical recommendations of a multidisciplinary groupSabrina Mariotti, Gabriele Minuti, Lorenza Landi, et al.
Journal of Translational Medicine|February 5, 2020
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatmentAndrea Botticelli, Pamela Vernocchi, Federico Marini, et al.
Translational Lung Cancer Research|June 24, 2021
Complete disease remission in a <i>TP53</i> and <i>KRAS</i> co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case reportShuai Zhu, Shikang Zhao, Qian Zhang, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Cancers|December 17, 2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a SignatureMarco Filetti, Mario Occhipinti, Alessio Cirillo, et al.
Anticancer Research|May 7, 2017
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with TaxanesSilvia Angelini, Andrea Botticelli, Concetta Elisa Onesti, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2025
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trialsFrancesco Guerrera, Filippo Tommaso Gallina, Eleonora Balzani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2026
Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysisPietro Bertoglio, Filippo Tommaso Gallina, Eleonora Balzani, et al.
Future Oncology (London, England)|November 15, 2017
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerGiulio Metro, Antonio Passaro, Giuseppe Lo Russo, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Biomedicines|August 28, 2025
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target TherapyDaria Maria Filippini, Donatella Romaniello, Francesca Carosi, et al.
Heliyon|December 17, 2024
Simultaneous care provision to patients with small cell lung cancer in Lazio region: Practical recommendations of a multidisciplinary groupSabrina Mariotti, Gabriele Minuti, Lorenza Landi, et al.
Journal of Translational Medicine|February 5, 2020
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatmentAndrea Botticelli, Pamela Vernocchi, Federico Marini, et al.
Translational Lung Cancer Research|June 24, 2021
Complete disease remission in a <i>TP53</i> and <i>KRAS</i> co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case reportShuai Zhu, Shikang Zhao, Qian Zhang, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Cancers|December 17, 2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a SignatureMarco Filetti, Mario Occhipinti, Alessio Cirillo, et al.
Anticancer Research|May 7, 2017
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with TaxanesSilvia Angelini, Andrea Botticelli, Concetta Elisa Onesti, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2025
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trialsFrancesco Guerrera, Filippo Tommaso Gallina, Eleonora Balzani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2026
Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysisPietro Bertoglio, Filippo Tommaso Gallina, Eleonora Balzani, et al.
Future Oncology (London, England)|November 15, 2017
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerGiulio Metro, Antonio Passaro, Giuseppe Lo Russo, et al.
Pageof 14